Rhoen Klinikum AG logo

Rhoen Klinikum AG

XTER:RHK (Germany)   Ordinary Shares
€ 12.30 (-1.6%) May 8
21.21
P/B:
0.66
Market Cap:
€ 823.34M ($ 887.77M)
Enterprise V:
€ 620.40M ($ 668.95M)
Volume:
801.00
Avg Vol (2M):
3.03K
Also Trade In:
Volume:
801.00
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Rhoen Klinikum AG ( XTER:RHK ) from 1990 to May 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Rhoen Klinikum AG stock (XTER:RHK) PE ratio as of May 09 2024 is 21.21. More Details

Rhoen Klinikum AG (XTER:RHK) PE Ratio (TTM) Chart

To

Rhoen Klinikum AG (XTER:RHK) PE Ratio (TTM) Historical Data

Total 1234
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Rhoen Klinikum AG PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-10 21.2 2024-03-04 21.2
2024-05-08 21.2 2024-03-01 21.7
2024-05-07 21.6 2024-02-29 21.2
2024-05-06 21.6 2024-02-28 19.1
2024-05-03 21.4 2024-02-27 17.9
2024-05-02 22.2 2024-02-26 17.0
2024-04-30 22.8 2024-02-23 16.6
2024-04-29 22.9 2024-02-22 16.6
2024-04-26 22.2 2024-02-21 16.7
2024-04-25 22.1 2024-02-20 16.7
2024-04-24 22.2 2024-02-19 17.0
2024-04-23 22.4 2024-02-16 16.9
2024-04-22 20.3 2024-02-15 17.0
2024-04-19 18.8 2024-02-14 17.0
2024-04-18 18.8 2024-02-13 16.7
2024-04-17 18.6 2024-02-12 16.6
2024-04-16 19.1 2024-02-09 16.8
2024-04-15 19.7 2024-02-08 16.9
2024-04-12 19.7 2024-02-07 16.5
2024-04-11 19.3 2024-02-06 16.9
2024-04-10 20.0 2024-02-05 17.1
2024-04-09 20.0 2024-02-02 17.4
2024-04-08 20.3 2024-02-01 17.2
2024-04-05 20.2 2024-01-31 17.2
2024-04-04 20.3 2024-01-30 17.4
2024-04-03 20.2 2024-01-29 17.4
2024-04-02 20.3 2024-01-26 17.2
2024-03-28 19.0 2024-01-25 17.1
2024-03-27 19.0 2024-01-24 17.1
2024-03-26 18.4 2024-01-23 17.0
2024-03-25 19.3 2024-01-22 17.2
2024-03-22 19.3 2024-01-19 17.4
2024-03-21 19.8 2024-01-18 17.4
2024-03-20 19.3 2024-01-17 17.2
2024-03-19 19.1 2024-01-16 17.2
2024-03-18 19.3 2024-01-12 17.2
2024-03-15 19.5 2024-01-11 17.2
2024-03-14 19.7 2024-01-10 17.1
2024-03-13 19.8 2024-01-09 17.2
2024-03-12 19.3 2024-01-08 17.2
2024-03-11 20.2 2024-01-05 17.4
2024-03-08 20.2 2024-01-04 17.4
2024-03-07 20.5 2024-01-03 17.4
2024-03-06 20.3 2024-01-02 17.6
2024-03-05 21.2 2023-12-29 17.2

Rhoen Klinikum AG (XTER:RHK) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Rhoen Klinikum AG provides medical care focused in five key areas: cardiovascular medicine, neuromedicine, oncology, pulmonary diseases, and orthopedic and trauma surgery. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on an outpatient basis. Rhoen Klinikum generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the largest proportions of revenue.